Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response (Q35223807)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response |
scientific article |
Statements
1 reference
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response (English)
1 reference
Yusuf A Hannun
1 reference
Sahar A Saddoughi
1 reference
Elizabeth Garrett-Mayer
1 reference
Uzair Chaudhary
1 reference
Paul E O'Brien
1 reference
Larry B Afrin
1 reference
Terry A Day
1 reference
M Boyd Gillespie
1 reference
Anand K Sharma
1 reference
Christina S Wilhoit
1 reference
Robin Bostick
1 reference
Can E Senkal
1 reference
Jacek Bielawski
1 reference
George R Simon
1 reference
Keisuke Shirai
1 reference
Besim Ogretmen
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference